Foxp3+ T-Regulatory Cells in Sjogren's Syndrome Correlation with the Grade of the Autoimmune Lesion and Certain Adverse Prognostic Factors

被引:125
作者
Christodoulou, Maria I. [1 ]
Kapsogeorgou, Efstathia K. [1 ]
Moutsopoulos, Niki M. [2 ]
Moutsopoulos, Haralampos M. [1 ]
机构
[1] Natl Univ Athens, Sch Med, Dept Pathophysiol, Immunol Lab, Athens 11527, Greece
[2] Natl Inst Dent & Craniofacial Res, Oral Infect & Immun Branch, NIH, Bethesda, MD USA
关键词
D O I
10.2353/ajpath.2008.080246
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Sjogren's syndrome (SS) is a chronic autoimmune exocrinopathy associated with variable lymphocytic infiltration of the affected organs (primarily salivary and lacrimal glands) and broad clinical manifestations, including lymphoma development. To investigate the potential implication of Foxp3(+) T-regulatory cells in the regulation of SS inflammatory responses, we studied their incidence in the minor salivary glands (MSGs) and their relationship with histopathological and clinical disease parameters. Similar percentages of infiltrating Foxp3(+) cells were observed in the MSG lesions of all SS patients (n = 30) and non-SS sialadenitis controls (n = 7). Foxp3(+) cells were not detected in sicca-complaining controls with negative biopsy (n = 6). In SS patients, Foxp3+ cell frequency varied according to lesion severity, with the highest and lowest frequencies obtained in intermediate and mild MSG lesions, respectively. In the peripheral blood of these patients, reverse distribution of Foxp3+ cells was observed. Furthermore, the frequency of Foxp3+ cells in the MSG lesions and peripheral blood was negatively associated (r = -0.6679, P = 0.0065). MSG-infiltrating Foxp3(+) cells were found to positively correlate with biopsy focus score (P = 0.05), infiltrating mononuclear cells, dendritic cells, and macrophages; (P <= 0.024 each), and serum C4 levels (P = 0.0328), whereas lower Foxp3(+) cell incidence correlated with adverse predictors for lymphoma development, such as the presence of C4 hypocomplementemia (P = 0.012) and SG enlargement (tendency, P = 0.067). our findings; suggest that the Foxp3(+) T-regulatory cell frequency in the MSG lesions of SS patients correlates with inflammation grade and certain risk factors for lymphoma development. (Am J Pathol 2008, 173:1389-1396; DOI: 10.2353/ajpath.2008.080246)
引用
收藏
页码:1389 / 1396
页数:8
相关论文
共 42 条
  • [1] Natural regulatory T cells in infectious disease
    Belkaid, Y
    Rouse, BT
    [J]. NATURE IMMUNOLOGY, 2005, 6 (04) : 353 - 360
  • [2] The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3
    Bennett, CL
    Christie, J
    Ramsdell, F
    Brunkow, ME
    Ferguson, PJ
    Whitesell, L
    Kelly, TE
    Saulsbury, FT
    Chance, PF
    Ochs, HD
    [J]. NATURE GENETICS, 2001, 27 (01) : 20 - 21
  • [3] How do CD4+CD25+ regulatory T cells control autoimmunity?
    Bluestone, JA
    Tang, QZ
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2005, 17 (06) : 638 - 642
  • [4] Natural versus adaptive regulatory T cells
    Bluestone, JA
    Abbas, AK
    [J]. NATURE REVIEWS IMMUNOLOGY, 2003, 3 (03) : 253 - 257
  • [5] A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3
    Fontenot, JD
    Rudensky, AY
    [J]. NATURE IMMUNOLOGY, 2005, 6 (04) : 331 - 337
  • [6] Foxp3-dependent programme of regulatory T-cell differentiation
    Gavin, Marc A.
    Rasmussen, Jeffrey P.
    Fontenot, Jason D.
    Vasta, Valeria
    Manganiello, Vincent C.
    Beavo, Joseph A.
    Rudensky, Alexander Y.
    [J]. NATURE, 2007, 445 (7129) : 771 - 775
  • [7] Gerli R, 1997, BRIT J RHEUMATOL, V36, P969
  • [8] CD4 CD25high regulatory T cells are not impaired in patients with primary Sjogren's syndrome
    Gottenberg, JE
    Lavie, F
    Abbed, K
    Gasnault, J
    Le Nevot, E
    Delfraissy, JF
    Taoufik, Y
    Mariette, X
    [J]. JOURNAL OF AUTOIMMUNITY, 2005, 24 (03) : 235 - 242
  • [9] Control of regulatory T cell development by the transcription factor Foxp3
    Hori, S
    Nomura, T
    Sakaguchi, S
    [J]. SCIENCE, 2003, 299 (5609) : 1057 - 1061
  • [10] Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren's syndrome
    Ioannidis, JPA
    Vassiliou, VA
    Moutsopoulos, HM
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (03): : 741 - 747